Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1017 of 6351
-
Which stent lasts longest? a Head-to-Head test for bile duct blockage
Disease control OngoingThe goal of this randomized controlled trial is to compare uncovered, partially covered, and fully covered self-expandable metal stents (SEMS) in the palliative treatment of distal malignant biliary obstruction in a Swedish multicenter study. The main questions it aims to answer…
Sponsor: Region Stockholm • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Could a blood vessel drug reverse sudden blindness in giant cell arteritis?
Disease control CompletedGiant cell arteritis , also named Horton's disease, is the most common vasculitis in subjects over 50 years old. The incidence increases with age : from 188 to 290 cases per million inhabitants per year, with a North-South gradient. The major risk of Horton's disease is blindnes…
Phase 3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy shows promise in tough lung cancer battle
Disease control CompletedThis study will evaluate the efficacy of tiragolumab plus atezolizumab and carboplatin and etoposide (CE) compared with placebo plus atezolizumab and CE in participants with chemotherapy-naive extensive-stage small cell lung cancer (ES-SCLC). Eligible participants will be stratif…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug aims to tame rare artery disease
Disease control OngoingThe main objective of this study is to evaluate the efficacy of upadacitinib in combination with a corticosteroid taper regimen compared to placebo in combination with a corticosteroid taper regimen.
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Drug cocktail aims to shrink Hard-to-Treat stomach cancers
Disease control CompletedThis is a phase 2 single-arm, open-label clinical trial determining efficacy of cabozantinib in combination with pembrolizumab in subjects with advanced gastric and gastroesophageal adenocarcinoma. These are subjects who have progressed, or not tolerated, at least one prior line …
Phase 2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Malaria vaccine plus bednets: a One-Two punch?
Prevention CompletedThe overall goal of this study is to assess the impact of RTS,S (malaria) vaccination and PBO nets on malaria infection and transmission, independently and how they interact when they are introduced together. The specific objectives for the study are as follows: 1. To estimate …
Sponsor: Michigan State University • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC
-
Engineered t cells take on deadly brain cancers
Disease control Recruiting nowIn this study, there are two treatment groups called Cohort 1 and Cohort 2. Cohort 1 is for patients with diffuse midline glioma, diffuse intrinsic pontine glioma, medulloblastoma, or another rare high-grade glioma that expresses GD2. Cohort 2 is for patients with a type of cance…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could allergy pills calm irritable bowel syndrome?
Disease control CancelledIrritable bowel syndrome is a functional disorder of the gastrointestinal tract diagnosed with the Rome criteria. The Rome IV criteria are based on abdominal pain symptoms and stool habits including stool frequency and stool forms \[1\]. They define 3 main subtypes based on sympt…
Phase 3 • Sponsor: University of Cincinnati • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
AI could predict who will survive a cardiac arrest
Knowledge-focused Recruiting nowThe overall incidence of cardiorespiratory arrest in Europe is estimated at 350,000 to 700,000 cases per year. Survival rate is estimated at 10.7% for all rhythm disorders combined. Several examples of AI application in the medical field exist. Ting et al have developed a comput…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Blood test could predict clot risk after heart valve surgery
Diagnosis Recruiting nowThis study aims to utilise novel biomarkers assessing thrombosis and thrombolysis (through a blood test), to identify patients undergoing either surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) who are at risk of thrombosis, and relate th…
Sponsor: East and North Hertfordshire NHS Trust • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC
-
One surgery, two problems? a new approach to pelvic floor repair
Disease control CompletedObstructive defecation syndrome (ODS) defines a disturbed defecation process frequently associated with pelvic organ prolapse (POP) in women. It substantially compromises quality of life and conservative treatment options are limited. In cases surgery is required the intervention…
Sponsor: Evangelisches Klinikum Köln Weyertal gGmbH • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a short tobacco break curb cannabis cravings?
Disease control PausedCannabis smokers who also smoke tobacco cigarettes have markedly higher rates of cannabis relapse relative to those who do not use tobacco. There is a clear need to develop and evaluate interventions for dual tobacco and cannabis users. The investigators of this study have previo…
Phase 2 • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Desperate measure: rerouting veins to save legs from amputation
Disease control Recruiting nowThe objective of the study is to evaluate early safety and effectiveness of the percutaneous deep foot venous arterialization performed in clinical practice, in an unselected population of patients with "no-option" CLTI.
Sponsor: EndoCore Lab s.r.l. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug could replace chemo for kids with brain tumor
Disease control Recruiting nowThis phase III trial compares the effect of selumetinib versus the standard of care treatment with carboplatin and vincristine (CV) in treating patients with newly diagnosed or previously untreated low-grade glioma (LGG) that does not have a genetic abnormality called BRAFV600E m…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Supercharged immune cells may make bone marrow transplants safer and more effective
Disease control Recruiting nowGamma delta T-cells are part of the innate immune system with the ability to recognize malignant cells and kill them. This study uses gamma delta T-cells to maximize the anti-tumor response and minimize graft versus host disease (GVHD) in leukemic and myelodysplastic patients who…
Phase 1 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo therapy targets aggressive brain tumors in phase 2 trial
Disease control Recruiting nowThis phase II trial studies how well temozolomide and radiation therapy work in treating patients with IDH wildtype historically lower grade gliomas or non-histological molecular glioblastomas. Radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors. Givin…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Gene-Matched blood transfusions could prevent dangerous antibodies in sickle cell patients
Disease control Recruiting nowTo determine the feasibility and efficacy of matching donor red cells by RH genotype for a cohort of chronically transfused patients with SCD.
Phase 1/2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New balloon method may improve stent success in Rock-Hard arteries
Disease control CompletedSeverely calcified coronary stenoses are difficult to treat with percutaneous coronary intervention (PCI) using current techniques and there is little specific evidence on how to best treat these cases. It is hypothesized that balloon lithoplasty is superior to conventional ballo…
Sponsor: Herlev and Gentofte Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Radiation boosts immunotherapy in kidney cancer trial
Disease control CompletedThis trial will evaluate the addition of cytoreductive stereotactic body radiation therapy (SBRT) to standard of care combination ipilimumab and nivolumab (I/N) versus I/N alone for the treatment of metastatic kidney cancer.
Phase 2 • Sponsor: Ontario Clinical Oncology Group (OCOG) • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New hope for kids with tough cancers: ponatinib trial launches
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of ponatinib in children aged 1 to \< 18 years with advanced leukemias, lymphomas, and solid tumors.
Phase 1/2 • Sponsor: Incyte Biosciences International Sàrl • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC